L
LianBio
Focused on bringing paradigm-shifting medicines to patients
About LianBio
LianBio operates at the intersection of global biotech innovation and the expansive healthcare market in China and major Asian regions. The company focuses on identifying and sourcing top-tier therapeutic opportunities and creating new treatment paradigms for first-in-class programs. LianBio's unique business model is designed to support leading biotech companies that have not previously engaged in development within China and other major Asian markets. By leveraging a global innovation mining platform and a China-centric execution strategy, LianBio facilitates access to these large and dynamic healthcare landscapes, enhancing global development initiatives for its partners.
Read full description
LianBio serves biotech companies looking to expand their reach into the Asian healthcare market. The company operates in the healthcare and biotechnology sectors, focusing on unmet medical needs and innovative treatment approaches. Its business model revolves around strategic and financial partnerships, enabling it to bring advanced medical science to patients in need. Revenue is generated through these partnerships, which often involve collaborative development and commercialization agreements.
At a glance
- Founded
- 2019
- Headquarters
- Pudong, China
- Listing
- IPO 2021
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Latest news
Press, funding announcements and product moves mentioning LianBio.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later14 investors entered at this stage
BlackRock
Perceptive Advisors
Sphera Funds Management
Logos Capital
Venrock
Tybourne Capital Management
Casdin Capital
Viking Global Investors
Farallon Capital Management
Wellington Management
Pfizer
RA Capital Management
Vida Ventures
T. Rowe Price
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about LianBio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See LianBio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.